Inivata Launches Major US Study To Back Liquid Biopsy Tech In Lung Cancer
Executive Summary
Cambridge University spin-out Inivata has launched a major US clinical validation study to evaluate its liquid biopsy approach against tissue-based diagnostic methods in non-small cell lung cancer patients.